Vaccine Stocks: The Beginning of the End?
The stock market started out the new week on a positive note, with sharp advances in major market benchmarks. As of 1:30 p.m. ET, the Dow Jones Industrial Average (DJINDICES: ^DJI) was up 720 points to 35,300. The S&P 500 (SNPINDEX: ^GSPC) gained 61 points to 4,599, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) rebounded 120 points to 15,206.
For the most part, optimism on Wall Street centered on hopes that the global economy would be able to withstand any short-term impacts of new COVID-19 variants and keep rebounding from the huge disruptions near the beginning of the pandemic. However, that sent vaccine stocks down sharply. Many investors now have to wonder: with their main growth driver seemingly starting to wind down, will vaccine stocks keep struggling going forward? Below, we'll look at just how bad the damage was and what could lie ahead for these companies.
Image source: Getty Images.
Source Fool.com
